Chemotherapy Without Acute Leukemia As Secondary Diagnosis with Mcc in Massachusetts
MS-DRG 846: Chemotherapy without acute leukemia as secondary diagnosis with mcc
$66,876typical hospital bill
$33,901typical amount paid
$29,455–$35,752range paid across 4 hospitals
Massachusetts hospitals billed Medicare a typical $66,876 for this stay in 2024, about 2.0 times what was actually paid. Medicare's payment depends mostly on the hospital's location and teaching role; the bill depends on the hospital's own price list, so bills vary far more than payments.
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | |
|---|---|---|---|---|---|
| Tufts Medical Center | Boston | 15 | $37,637 | $29,455 | |
| Beth Israel Deaconess Medical Center | Boston | 14 | $45,812 | $32,601 | |
| Brigham and Women's Hospital | Boston | 53 | $143,446 | $35,201 | |
| Massachusetts General Hospital | Boston | 42 | $87,940 | $35,752 |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.